Immune to Cancer: The CRI Blog
-
Immunotherapy Shines at ASH and ESMO IO Conferences
Two conferences, one in America and one in Europe, highlight immunotherapy's continued progress and the important contributions…
-
Trusted Charities for Holiday Giving
Trusted consumer watchdog organizations make it a little easier to decide where to give this holiday season with…
-
Cindy Stowell Continues to Inspire
Jeopardy! host Alex Trebek will make a special announcement on Tuesday, November 7th.
-
CRI Researcher Highlights New Technique to Aid Immunotherapy
Dr. Mohammad Rashidian’s nanobodies could help improve doctors’ decisions regarding immunotherapy.
-
Corporate Social Responsibility Gives Cancer Immunotherapy Research a “Wonderful Edge”
Cupid Intimates spearheaded a corporate social responsibility initiative that generated a $10,000 donation to CRI’s immunotherapy research…
-
CAR T Cell Immunotherapy Approved for Adult Non-Hodgkin Lymphoma Patients
FDA approves new immunotherapy–Yescarta (axicabtagene ciloleucel)–for adult patients with relapsed or refractory non-Hodgkin large B cell lymphoma.
-
CRI featured in USA Today’s End-of-Year Charity Giving Advice
CRI among 12 top-rated cancer charities within a subset of organizations doing good work in breast cancer…
-
Checkpoint Immunotherapy Approved for Patients with Stomach, Gastroesophageal, and Liver Cancer
Previously treated patients with these cancer types can now receive anti-PD-1 immunotherapy; nivolumab for HCC and pembrolizumab…
-
CICON17 Day 4 Recap: The Tumor Microenvironment and Oncolytic Viruses
The final day of CICON17 explored two newer immunotherapy approaches that reflect broader understanding of tumor-immune interactions…
Join CRI in Shaping the Future of Immunotherapy
Support the pioneering work of CRI in advancing immunotherapy.